Ginkgo Bioworks Holdings Inc Class A (DNA)

13.42
1.39 9.39
NYSE
Prev Close 14.81
Open 14.59
Day Low/High 13.11 / 14.70
52 Wk Low/High 8.90 / 14.88
Volume 3.58M
Exchange NYSE
Shares Outstanding 1957.39B
Market Cap 24.12B
Div & Yield N.A. (N.A)

Ginkgo Bioworks bears were gripping about Scorpion Capital alleged "front running" their DNA short analysis by purchasing puts.  Well, put activity is now way down - Friday's expiration was quite active - and Cathie Wood of ARK  has reported that it...

I have been adding to my short all week. And, I have added to short today (at $100.03).

There was a lot of reaction to the Ginkgo Bioworks Holdings short report on Twitter Wednesday not too long after it was published.

In two or three months, you won't hear a word on this again much like we've seen on so many other names.

DNA

A new short - Ginkgo Bioworks Holdings  , see here. More to come.

The mixed action on Monday is not a negative -- and here's why SPACs are getting interesting again.

But aggressive action by retail traders is one reason that I'm not too worried about a substantial correction at this time.